Bionomics Limited (BNOX) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 4 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for BNOX is $6.00, representing a +2,270.6% upside from the current price of $0.2531. Price targets range from a low of $6.00 to a high of $6.00.
